{"best_oa_location":{"endpoint_id":"14a3f53cc073382d916","evidence":"deprecated","host_type":"repository","is_best":true,"license":"cc-by-nc-nd","oa_date":"2007-04-01","pmh_id":"oai:ddfv.ufv.es:10641/3676","repository_institution":"Universidad Francisco de Vitoria","updated":"deprecated","url":"https://hdl.handle.net/10641/3676","url_for_landing_page":"https://hdl.handle.net/10641/3676","url_for_pdf":null,"version":"submittedVersion"},"data_standard":2,"doi":"10.1158/1535-7163.mct-06-0729","doi_url":"https://doi.org/10.1158/1535-7163.mct-06-0729","first_oa_location":{"endpoint_id":"14a3f53cc073382d916","evidence":"deprecated","host_type":"repository","is_best":true,"license":"cc-by-nc-nd","oa_date":"2007-04-01","pmh_id":"oai:ddfv.ufv.es:10641/3676","repository_institution":"Universidad Francisco de Vitoria","updated":"deprecated","url":"https://hdl.handle.net/10641/3676","url_for_landing_page":"https://hdl.handle.net/10641/3676","url_for_pdf":null,"version":"submittedVersion"},"genre":"journal-article","has_repository_copy":true,"is_oa":true,"is_paratext":false,"journal_is_in_doaj":false,"journal_is_oa":false,"journal_issn_l":"1535-7163","journal_issns":"1535-7163,1538-8514","journal_name":"Molecular Cancer Therapeutics","oa_locations":[{"endpoint_id":"14a3f53cc073382d916","evidence":"deprecated","host_type":"repository","is_best":true,"license":"cc-by-nc-nd","oa_date":"2007-04-01","pmh_id":"oai:ddfv.ufv.es:10641/3676","repository_institution":"Universidad Francisco de Vitoria","updated":"deprecated","url":"https://hdl.handle.net/10641/3676","url_for_landing_page":"https://hdl.handle.net/10641/3676","url_for_pdf":null,"version":"submittedVersion"}],"oa_locations_embargoed":[],"oa_status":"green","published_date":"2007-04-01","publisher":"American Association for Cancer Research (AACR)","title":"Levels of p27kip1 determine Aplidin sensitivity","updated":"2026-02-09T15:04:13Z","year":2007,"z_authors":[{"author_position":"first","is_corresponding":true,"raw_affiliation_strings":["1Experimental Therapeutics Programme and"],"raw_author_name":"Victoria Moneo"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["1Experimental Therapeutics Programme and"],"raw_author_name":"Beatriz G. Serelde"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["1Experimental Therapeutics Programme and"],"raw_author_name":"Juan F.M. Leal"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["1Experimental Therapeutics Programme and"],"raw_author_name":"Carmen Blanco-Aparicio"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["2Structural Biology and Biocomputing Programme, Spanish National Cancer Center;"],"raw_author_name":"Ramon Diaz-Uriarte"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["3PharmaMar R&D, Madrid, Spain"],"raw_author_name":"Miguel Aracil"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["3PharmaMar R&D, Madrid, Spain"],"raw_author_name":"Juan C. Tercero"},{"author_position":"middle","is_corresponding":false,"raw_affiliation_strings":["3PharmaMar R&D, Madrid, Spain"],"raw_author_name":"Jose\u0301 Jimeno"},{"author_position":"last","is_corresponding":false,"raw_affiliation_strings":["1Experimental Therapeutics Programme and"],"raw_author_name":"Amancio Carnero"}]}